Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia

BACKGROUND: After the approval of dutastride for androgenic alopecia (AGA) in 2009, Korean authority required a post-marketing surveillance to obtain further data on its safety profile. OBJECTIVE: The objective was to monitor adverse events (AEs) of dutasteride 0.5 mg in Korean AGA male patients in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Dermatol
Autori principali: Choi, Gwang Seong, Kim, Joon Hyung, Oh, Shin-Young, Park, Jung-Min, Hong, Ji-Soo, Lee, Yil-Seob, Lee, Won-Soo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4969473/
https://ncbi.nlm.nih.gov/pubmed/27489426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2016.28.4.444
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi